Bionano Genomics (BNGO) Competitors $0.20 -0.01 (-4.01%) (As of 09:48 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BNGO vs. OWLT, OPXS, OMIC, CLIR, MSAI, RPID, AATC, PRE, AXDX, and OPTXShould you be buying Bionano Genomics stock or one of its competitors? The main competitors of Bionano Genomics include Owlet (OWLT), Optex Systems (OPXS), Singular Genomics Systems (OMIC), ClearSign Technologies (CLIR), MultiSensor AI (MSAI), Rapid Micro Biosystems (RPID), Autoscope Technologies (AATC), Prenetics Global (PRE), Accelerate Diagnostics (AXDX), and Syntec Optics (OPTX). These companies are all part of the "measuring and control equipment" industry. Bionano Genomics vs. Owlet Optex Systems Singular Genomics Systems ClearSign Technologies MultiSensor AI Rapid Micro Biosystems Autoscope Technologies Prenetics Global Accelerate Diagnostics Syntec Optics Bionano Genomics (NASDAQ:BNGO) and Owlet (NYSE:OWLT) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership. Do analysts prefer BNGO or OWLT? Bionano Genomics currently has a consensus price target of $1.50, suggesting a potential upside of 616.33%. Given Bionano Genomics' stronger consensus rating and higher probable upside, equities analysts clearly believe Bionano Genomics is more favorable than Owlet.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bionano Genomics 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Owlet 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, BNGO or OWLT? Bionano Genomics has a beta of 2.37, indicating that its share price is 137% more volatile than the S&P 500. Comparatively, Owlet has a beta of 1.56, indicating that its share price is 56% more volatile than the S&P 500. Do institutionals and insiders believe in BNGO or OWLT? 11.4% of Bionano Genomics shares are owned by institutional investors. Comparatively, 72.6% of Owlet shares are owned by institutional investors. 1.4% of Bionano Genomics shares are owned by company insiders. Comparatively, 67.1% of Owlet shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Does the media prefer BNGO or OWLT? In the previous week, Bionano Genomics had 4 more articles in the media than Owlet. MarketBeat recorded 8 mentions for Bionano Genomics and 4 mentions for Owlet. Owlet's average media sentiment score of 0.88 beat Bionano Genomics' score of -0.01 indicating that Owlet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bionano Genomics 0 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Owlet 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings and valuation, BNGO or OWLT? Owlet has higher revenue and earnings than Bionano Genomics. Owlet is trading at a lower price-to-earnings ratio than Bionano Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBionano Genomics$36.12M0.59-$232.49M-$2.32-0.09Owlet$78.58M0.90-$32.90M-$2.39-1.85 Is BNGO or OWLT more profitable? Owlet has a net margin of -13.23% compared to Bionano Genomics' net margin of -407.34%. Owlet's return on equity of 0.00% beat Bionano Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Bionano Genomics-407.34% -154.45% -80.78% Owlet -13.23%N/A -8.42% Does the MarketBeat Community prefer BNGO or OWLT? Bionano Genomics received 158 more outperform votes than Owlet when rated by MarketBeat users. Likewise, 64.03% of users gave Bionano Genomics an outperform vote while only 16.67% of users gave Owlet an outperform vote. CompanyUnderperformOutperformBionano GenomicsOutperform Votes16264.03% Underperform Votes9135.97% OwletOutperform Votes416.67%Underperform Votes2083.33% SummaryOwlet beats Bionano Genomics on 9 of the 17 factors compared between the two stocks. Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners…Claim your FREE 2024 Gold Guide Get Bionano Genomics News Delivered to You Automatically Sign up to receive the latest news and ratings for BNGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNGO vs. The Competition Export to ExcelMetricBionano GenomicsAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.36M$5.07B$5.06B$8.82BDividend YieldN/A0.46%5.18%4.07%P/E Ratio-0.0923.87126.3117.81Price / Sales0.594.391,178.7474.57Price / CashN/A40.7033.8632.53Price / Book0.102.084.684.68Net Income-$232.49M$515,312.50$119.54M$226.08M7 Day Performance-18.17%-5.56%-1.83%-1.04%1 Month Performance-34.66%-8.12%-3.60%1.04%1 Year Performance-85.56%-17.04%31.91%26.28% Bionano Genomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNGOBionano Genomics1.3815 of 5 stars$0.20-4.0%$1.50+646.3%-85.7%$20.50M$36.12M-0.09300Gap UpOWLTOwlet1.1758 of 5 stars$4.40-0.2%N/A-25.3%$70.58M$54M0.00106OPXSOptex Systems0.6335 of 5 stars$9.07-0.2%N/A+118.5%$62.31M$25.66M14.91122OMICSingular Genomics Systems1.915 of 5 stars$21.90+1.8%$10.75-50.9%+80.1%$54.97M$2.91M0.00220CLIRClearSign Technologies1.7232 of 5 stars$1.05+8.0%$6.00+471.4%+5.3%$52.74M$2.40M0.0010Analyst ForecastNews CoverageGap UpMSAIMultiSensor AI3.1731 of 5 stars$1.66+0.6%$8.00+381.9%N/A$50.53M$5.43M0.0035Analyst RevisionRPIDRapid Micro Biosystems0.9515 of 5 stars$1.15+6.5%N/A+5.9%$49.48M$22.52M0.00193Gap UpAATCAutoscope TechnologiesN/A$8.01+0.1%N/A+23.5%$43.82M$13.13M9.0940Ex-DividendPREPrenetics Global2.0059 of 5 stars$4.58-3.0%$9.00+96.5%+0.4%$41.86M$21.74M0.001Gap DownAXDXAccelerate Diagnostics2.4379 of 5 stars$1.63-4.1%$1.00-38.7%-67.0%$40.82M$12.06M0.00134OPTXSyntec Optics0.3984 of 5 stars$0.89-2.6%N/A-88.0%$32.82M$29.44M0.003Gap Up Related Companies and Tools Related Companies OWLT Alternatives OPXS Alternatives OMIC Alternatives CLIR Alternatives MSAI Alternatives RPID Alternatives AATC Alternatives PRE Alternatives AXDX Alternatives OPTX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BNGO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bionano Genomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bionano Genomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BNGO Stock Alerts